LDL Management in ACS: Lower is better but is Earlier better?
LIVE SESSION
Topic: Acute Coronary Syndromes – Prevention
Session type: Industry Live
Date: Time:* -

See more details
Watch Replay
Chairpersons
Marc Sabatine (Boston, United States of America)
Gilles Montalescot (Paris, France)
Subtitle
Sponsored by Amgen (Europe) GmbH
Learning objectives
- Confirm lower LDL-C beneficially impacts CV outcomes in high CV risk patients - Rationalise benefits of achieving lower and earlier LDL-C levels - Using real-world evidence, challenge reimbursement restrictions on PCSK9i use for high CV risk patients
Presentations
LDL Management in ACS: Lower is better but is Earlier better? - Sponsored by Amgen (Europe) GmbH
Speaker: Gilles Montalescot (Paris, France), Marc Sabatine (Boston, United States of America), Thorsten Leucker (Baltimore, United States of America)
Time:

Does earlier treatment impact CV outcomes?
Speaker: Marc Sabatine (Boston, United States of America)
Time:

Striking while the plaque is hot: emerging evidence.
Speaker: Thorsten Leucker (Baltimore, United States of America), Stephen James Nicholls (Melbourne, Australia)
Time:

What is the relevance to everyday practice?
Speaker: Gilles Montalescot (Paris, France)
Time:

Live Panel discussion and close.
Time: